George Soros’s Vertex Pharmaceuticals VRTX Stock Holding History

George Soros’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,600	Closed	-$394K	–	309
2017 Q1	$394K	Buy	+3,600	New	+$317K	0.01%	181
2016 Q3	–	Sell	-6,300	Closed	-$542K	–	267
2016 Q2	$542K	Buy	+6,300	New	+$544K	0.01%	145
2015 Q2	–	Sell	-56,912	Closed	-$6.71M	–	291
2015 Q1	$6.71M	Buy	+56,912	New	+$6.82M	0.07%	151
2014 Q2	–	Sell	-10,000	Closed	-$707K	–	438
2014 Q1	$707K	Buy	+10,000	New	+$792K	0.01%	254

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

George Soros's VRTX Position: Q2 2017 in Review

George Soros sold out of Vertex Pharmaceuticals (VRTX) in Q2 2017, closing a stake of 3,600 shares — an estimated $394K sold.

George Soros first reported a position in VRTX in Q1 2014 and held it in 4 quarters. The position peaked at $6.71M in Q1 2015. 582 funds tracked by Wall St. Rank hold VRTX as of Q2 2017.

George Soros reported no remaining Vertex Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
George Soros sold 3,600 Vertex Pharmaceuticals shares in Q2 2017, an estimated $394K.
George Soros first reported a position in Vertex Pharmaceuticals in Q1 2014 and held it in 4 quarters.
George Soros's Vertex Pharmaceuticals position peaked at $6.71M in Q1 2015.
582 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2017.

Based on Soros Fund Management's 13F filing for Q2 2017, filed 14 Aug 2017.